Clinical indications for this novel medicine will expand.
Sweaty hands, feet, legs, cholinergic urticaria, excess secretions, bronchospasm, colic, pupillary dilation, motion sickness etc
Botanix market cap of $20B on the back of this clinically useful ultra-short acting anticholinergic.
Clinical indications for this novel medicine will expand.Sweaty...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $606.3M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 32.0¢ | $1.459M | 4.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 271241 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 243220 | 6 |
View Market Depth
| Last trade - 15.06pm 09/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |